Gut microbiota and probiotics: Focus on diabetes mellitus

References

• Agarwal, R. (2006). Anti-inflammatory effects of short-term pioglitazone therapy in men with advanced diabetic nephropathy. Am. J. Physiol. - Renal Physiol. 290:600–605.
   PubMed Web of Science ®Google Scholar
• Agerholm-Larsen, L., Bell, M. L., Grunwald, G. K. and Astrup, A. (2000). The effect of a probiotic milk product on plasma cholesterol: A meta-analysis of short-term intervention studies. Eur. J. Clin. Nutr. 54:856–860.
   PubMed Web of Science ®Google Scholar
• Al-Salami, H., Butt, G., Fawcett, J., Tucker, I., Golocorbin-Kon, S. and Mikov, M. (2008a). Probiotic treatment reduces blood glucose levels and increases systemic absorption of gliclazide in diabetic rats. Eur. J. Drug Metab. Pharm. 33:101–106.
   PubMed Web of Science ®Google Scholar
• Al-Salami, H., Butt, G., Tucker, I. and Mikov, M. (2008b). Influence of the semisynthetic bile acid MKC on the ileal permeation of gliclazide in vitro in healthy and diabetic rats treated with probiotics. Meth. Findings Exp. Clin. Pharm. 30:107–113.
   PubMed Web of Science ®Google Scholar
• Alokail, M., Sabico, S., Al-Saleh, Y., Al-Daghri, N., Alkharfy, K., Vanhoutte, P. and McTernan, P. (2013). Effects of probiotics in patients with diabetes mellitus type 2: Study protocol for a randomized, double-blind, placebo-controlled trial. Trials 14:195.
   PubMedGoogle Scholar
• Anderson, J. W. and Gilliland, S. E. (1999). Effect of fermented milk (yogurt) containing Lactobacillus acidophilus L1 on serum cholesterol in hypercholesterolemic humans. J. Am. Coll. Nutr. 18:43–50.
   PubMed Web of Science ®Google Scholar
• Andersson, U., Bränning, C., Ahrné, S., Molin, G., Alenfall, J., Önning, G., Nyman, M. and Holm, C. (2010). Probiotics lower plasma glucose in the high-fat fed C57BL/6J mouse. Beneficial Microbes. 1:189–196.
   PubMed Web of Science ®Google Scholar
• Andreasen, A. S., Larsen, N., Pedersen-Skovsgaard, T., Berg, R. M. G., Møller, K., Svendsen, K. D., Jakobsen, M. and Pedersen, B. K. (2010). Effects of Lactobacillus acidophilus NCFM on insulin sensitivity and the systemic inflammatory response in human subjects. Brit. J. Nutr. 104:1831–1838.
   PubMed Web of Science ®Google Scholar
• Arumugam, M., Raes, J., Pelletier, E., Le Paslier, D., Yamada, T., Mende, D. R., Fernandes, G. R., Tap, J., Bruls, T., Batto, J. M., Bertalan, M., Borruel, N., Casellas, F., Fernandez, L., Gautier, L., Hansen, T., Hattori, M., Hayashi, T., Kleerebezem, M., Kurokawa, K., Leclerc, M., Levenez, F., Manichanh, C., Nielsen, H. B., Nielsen, T., Pons, N., Poulain, J., Qin, J., Sicheritz-Ponten, T., Tims, S., Torrents, D., Ugarte, E., Zoetendal, E. G., Wang, J., Guarner, F., Pedersen, O., de Vos, W. M., Brunak, S., Dore, J., Antolin, M., Artiguenave, F., Blottiere, H. M., Almeida, M., Brechot, C., Cara, C., Chervaux, C., Cultrone, A., Delorme, C., Denariaz, G., Dervyn, R., Foerstner, K. U., Friss, C., van de Guchte, M., Guedon, E., Haimet, F., Huber, W., van Hylckama-Vlieg, J., Jamet, A., Juste, C., Kaci, G., Knol, J., Lakhdari, O., Layec, S., Le Roux, K., Maguin, E., Merieux, A., Melo Minardi, R., M'Rini, C., Muller, J., Oozeer, R., Parkhill, J., Renault, P., Rescigno, M., Sanchez, N., Sunagawa, S., Torrejon, A., Turner, K., Vandemeulebrouck, G., Varela, E., Winogradsky, Y., Zeller, G., Weissenbach, J., Ehrlich, S. D. and Bork, P. (2011). Enterotypes of the human gut microbiome. Nature. 473:174–180.
   PubMed Web of Science ®Google Scholar
• Asemi, Z., Khorrami-Rad, A., Alizadeh, S.-A., Shakeri, H. and Esmaillzadeh, A. (2014). Effects of synbiotic food consumption on metabolic status of diabetic patients: A double-blind randomized cross-over controlled clinical trial. Clin. Nutr. 33:198–203.
   PubMed Web of Science ®Google Scholar
• Asemi, Z., Zare, Z., Shakeri, H., Sabihi, S. and Esmaillzadeh, A. (2013). Effect of multispecies probiotic supplements on metabolic profiles, hs-CRP, and oxidative stress in patients with type 2 diabetes. Ann. Nutr. Metab. 63:1–9.
   PubMed Web of Science ®Google Scholar
• Ataie-Jafari, A., Larijani, B., Alavi Majd, H. and Tahbaz, F. (2009). Cholesterol-lowering effect of probiotic yogurt in comparison with ordinary yogurt in mildly to moderately hypercholesterolemic subjects. Ann. Nutr. Metab. 54:22–27.
   PubMed Web of Science ®Google Scholar
• Azaïs-Braesco, V., Bresson, J. L., Guarner, F. and Corthier, G. (2010). Not all lactic acid bacteria are probiotics, …but some are. Brit. J. Nutr. 103:1079–1081.
   PubMedGoogle Scholar
• Backhed, F., Ding, H., Wang, T., Hooper, L. V., Koh, G. Y., Nagy, A., Semenkovich, C. F. and Gordon, J. I. (2004). The gut microbiota as an environmental factor that regulates fat storage. Proc. Natl. Acad. Sci. USA. 101:15718–15723.
   PubMed Web of Science ®Google Scholar
• Baggio, L. L. and Drucker, D. J. (2007). Biology of Incretins: GLP-1 and GIP. Gastroenterology. 132:2131–2157.
   PubMed Web of Science ®Google Scholar
• Bejar, W., Hamden, K., Ben Salah, R. and Chouayekh, H. (2013). Lactobacillus plantarum TN627 significantly reduces complications of alloxan-induced diabetes in rats. Anaerobe. 24:4–11.
   PubMed Web of Science ®Google Scholar
• Cani, P., Neyrinck, A., Fava, F., Knauf, C., Burcelin, R., Tuohy, K., Gibson, G. and Delzenne, N. (2007a). Selective increases of bifidobacteria in gut microflora improve high-fat-diet-induced diabetes in mice through a mechanism associated with endotoxaemia. Diabtologia. 50:2374–2383.
   PubMed Web of Science ®Google Scholar
• Cani, P. D., Amar, J., Iglesias, M. A., Poggi, M., Knauf, C., Bastelica, D., Neyrinck, A. M., Fava, F., Tuohy, K. M., Chabo, C., Waget, A., Delmee, E., Cousin, B., Sulpice, T., Chamontin, B., Ferrieres, J., Tanti, J. F., Gibson, G. R., Casteilla, L., Delzenne, N. M., Alessi, M. C. and Burcelin, R. (2007b). Metabolic endotoxemia initiates obesity and insulin resistance. Diabetes. 56:1761–1772.
   PubMed Web of Science ®Google Scholar
• Cani, P. D., Bibiloni, R., Knauf, C., Waget, A., Neyrinck, A. M., Delzenne, N. M. and Burcelin, R. (2008). Changes in gut microbiota control metabolic endotoxemia-induced inflammation in high-fat diet-induced obesity and diabetes in mice. Diabetes. 57:1470–1481.
   PubMed Web of Science ®Google Scholar
• Cani, P. D. and Delzenne, N. M. (2007). Gut microflora as a target for energy and metabolic homeostasis. Curr. Opin. Clin. Nutr. Metab. Care. 10:729–734.
   PubMed Web of Science ®Google Scholar
• Cani, P. D., Lecourt, E., Dewulf, E. M., Sohet, F. M., Pachikian, B. D., Naslain, D., De Backer, F., Neyrinck, A. M. and Delzenne, N. M. (2009a). Gut microbiota fermentation of prebiotics increases satietogenic and incretin gut peptide production with consequences for appetite sensation and glucose response after a meal. Am. J. Clin. Nutr. 90:1236–1243.
   PubMed Web of Science ®Google Scholar
• Cani, P. D., Possemiers, S., Van de Wiele, T., Guiot, Y., Everard, A., Rottier, O., Geurts, L., Naslain, D., Neyrinck, A., Lambert, D. M., Muccioli, G. G. and Delzenne, N. M. (2009b). Changes in gut microbiota control inflammation in obese mice through a mechanism involving GLP-2-driven improvement of gut permeability. Gut. 58:1091–1103.
   PubMed Web of Science ®Google Scholar
• Cani, P. D., Geurts, L., Matamoros, S., Plovier, H. and Duparc, T. (2014). Glucose metabolism: Focus on gut microbiota, the endocannabinoid system and beyond. Diabetes Metab.
   PubMedGoogle Scholar
• Carvalho-Filho, M. A., Ueno, M., Hirabara, S. M., Seabra, A. B., Carvalheira, J. B. C., de Oliveira, M. G., Velloso, L. A., Curi, R. and Saad, M. J. A. (2005). S-Nitrosation of the insulin receptor, insulin receptor Substrate 1, and protein kinase B/Akt: A novel mechanism of insulin resistance. Diabetes. 54:959–967.
   PubMed Web of Science ®Google Scholar
• Castellazzi, A. M., Valsecchi, C., Montagna, L., Malfa, P., Ciprandi, G., Avanzini, M. A. and GL., M. (2007). In vitro activation of mononuclear cells by two probiotics: Lactobacillus paracasei I 1688, Lactobacillus salivarius I 1794, and their mixture (PSMIX). Immunol. Invest. 36:413–421.
   PubMed Web of Science ®Google Scholar
• Ceriello, A. and Motz, E. (2004). Is oxidative stress the pathogenic mechanism underlying insulin resistance, diabetes, and cardiovascular diseas e? The common soil hypothesis revisited. Arterioscler. Thromb. Vasc. Biol. 24:816–823.
   PubMed Web of Science ®Google Scholar
• Chandra, R. K. (1992). Effect of vitamin and trace-element supplementation on immune responses and infection in elderly subjects. The Lancet. 340:1124–1127.
   PubMed Web of Science ®Google Scholar
• Choi, S. W., Benzie, I. F., Ma, S. W., Strain, J. J. and Hannigan, B. M. (2008). Acute hyperglycemia and oxidative stress: direct cause and effect? Free Radical Biol. Med. 44:1217–1231.
   PubMed Web of Science ®Google Scholar
• Claesson, M. J., Jeffery, I. B., Conde, S., Power, S. E., O'Connor, E. M., Cusack, S., Harris, H. M. B., Coakley, M., O'Sullivan, O., Fitzgerald, G. F., Deane, J., O'Connor, M., Harnedy, N., O'Connor, K., O'Mahony, D., van Sinderen, D., Wallace, M., Brennan, L., Stanton, C., Marchesi, J. R., Fitzgerald, A. P., Shanahan, F., Hill, C., Ross, R. P. and O'Toole, P. W. (2012). Gut microbiota composition correlates with diet and health in the elderly. Nature. 488:178–184.
   PubMed Web of Science ®Google Scholar
• Cross, M. L., Ganner, A., Teilab, D. and Fray, L. M. (2004). Patterns of cytokine induction by gram-positive and gram-negative probiotic bacteria. FEMS Immunol. Med. Microbiol. 42:173–180.
   PubMed Web of Science ®Google Scholar
• Czinn S. J. and S. S. Blanchard. (2009). Probiotics in foods and supplements. In: Michail S. and P. M. Sherman (eds). Nutrition and health: Probiotics in Pediatric Medicine, pp. 299–306. Totowa: Humana Press.
   Google Scholar
• D'Eon, T. M., Pierce, K. A., Roix, J. J., Tyler, A., Chen, H. and Teixeira, S. R. (2008). The role of adipocyte insulin resistance in the pathogenesis of obesity-related elevations in endocannabinoids. Diabetes. 57:1262–1268.
   PubMed Web of Science ®Google Scholar
• Dandona, P., Aljada, A., Chaudhuri, A. and Mohanty, P. (2004). Endothelial dysfunction, inflammation and diabetes. Rev. Endocr. Metab. Disord. 5:189–197.
   PubMed Web of Science ®Google Scholar
• De Vuyst, L. and Leroy, F. (2011). Cross-feeding between bifidobacteria and butyrate-producing colon bacteria explains bifidobacterial competitiveness, butyrate production, and gas production. Int. J. Food Microbiol. 149:73–80.
   PubMed Web of Science ®Google Scholar
• DiRienzo, D. B. (2014). Effect of probiotics on biomarkers of cardiovascular disease: Implications for heart-healthy diets. Nutr. Rev. 72:18–29.
   PubMed Web of Science ®Google Scholar
• Dobrian, A. D., Schriver, S. D., Khraibi, A. A. and Prewitt, R. L. (2004). Pioglitazone prevents hypertension and reduces oxidative stress in diet-induced obesity. Hypertension. 43:48–56.
   PubMed Web of Science ®Google Scholar
• Dong, H., Rowland, I. and Yaqoob, P. (2012). Comparative effects of six probiotic strains on immune function in vitro. Brit. J. Nutr. 108:459–470.
   PubMed Web of Science ®Google Scholar
• Drago, L., Nicola, L., Iemoli, E., Banfi, G. and De Vecchi, E. (2010). Strain-dependent release of cytokines modulated by Lactobacillus salivarius human isolates in an in vitro model. BMC Res. Notes. 3:44.
   PubMedGoogle Scholar
• Eckburg, P. B., Bik, E. M., Bernstein, C. N., Purdom, E., Dethlefsen, L., Sargent, M., Gill, S. R., Nelson, K. E. and Relman, D. A. (2005). Diversity of the human intestinal microbial flora. Science. 308:1635–1638.
   PubMed Web of Science ®Google Scholar
• Ejtahed, H. S., Mohtadi-Nia, J., Homayouni-Rad, A., Niafar, M., Asghari-Jafarabadi, M. and Mofid, V. (2012). Probiotic yogurt improves antioxidant status in type 2 diabetic patients. Nutr. (Burbank, Los Angeles County, Calif.). 28:539–543.
   PubMed Web of Science ®Google Scholar
• Ejtahed, H. S., Mohtadi-Nia, J., Homayouni-Rad, A., Niafar, M., Asghari-Jafarabadi, M., Mofid, V. and Akbarian-Moghari, A. (2011). Effect of probiotic yogurt containing Lactobacillus acidophilus and Bifidobacterium lactis on lipid profile in individuals with type 2 diabetes mellitus. J. Dairy Sci. 94:3288–3294.
   PubMed Web of Science ®Google Scholar
• Esposito, K., Nappo, F., Marfella, R., Giugliano, G., Giugliano, F., Ciotola, M., Quagliaro, L., Ceriello, A. and Giugliano, D. (2002). Inflammatory cytokine concentrations are acutely increased by hyperglycemia in humans: Role of oxidative stress. Circulation. 106:2067–2072.
   PubMed Web of Science ®Google Scholar
• Fabian, E. and Elmadfa, I. (2007). The effect of daily consumption of probiotic and conventional yoghurt on oxidant and anti-oxidant parameters in plasma of young healthy women. Int. J. Vitam. Nutr. Res. 77:79–88.
   PubMed Web of Science ®Google Scholar
• FAO/WHO Working Group Report on Drafting Guidelines for the Evaluation of Probiotics in Food. London, Ontario, Canada, April 30, 2002 and May 1, 2002.
   Google Scholar
• FAO and WHO (2002). Report of a joint FAO/WHO working group on drafting guidelines for the evaluation of probiotics in food. Guidelines for evaluation of probiotics in food. London, Ontario, Canada.
   Google Scholar
• Fink, L. N., Zeuthen, L. H., Christensen, H. R., Morandi, B., Frøkiær, H. and Ferlazzo, G. (2007). Distinct gut-derived lactic acid bacteria elicit divergent dendritic cell-mediated NK cell responses. Int. Immunol. 19:1319–1327.
   PubMed Web of Science ®Google Scholar
• Gao, Z., Yin, J., Zhang, J., Ward, R. E., Martin, R. J., Lefevre, M., Cefalu, W. T. and Ye, J. (2009). Butyrate improves insulin sensitivity and increases energy expenditure in mice. Diabetes. 58:1509–1517.
   PubMed Web of Science ®Google Scholar
• Garay-Malpartida, H., Mourão, R., Mantovani, M., Santos, I., Sogayar, M. and Goldberg, A. (2011). Toll-like receptor 4 (TLR4) expression in human and murine pancreatic beta-cells affects cell viability and insulin homeostasis. BMC Immunol. 12:1–8.
   PubMedGoogle Scholar
• Ghadimi, D., Fölster-Holst, R., de Vrese, M., Winkler, P., Heller, K. J. and Schrezenmeir, J. (2008). Effects of probiotic bacteria and their genomic DNA on TH1/TH2-cytokine production by peripheral blood mononuclear cells (PBMCs) of healthy and allergic subjects. Immunobiology. 213:677–692.
   PubMed Web of Science ®Google Scholar
• Gill, H. S., Rutherfurd, K. J., Cross, M. L. and Gopal, P. K. (2001). Enhancement of immunity in the elderly by dietary supplementation with the probiotic Bifidobacterium lactis HN019. Am. J. Clin. Nutr. 74:833–839.
   PubMed Web of Science ®Google Scholar
• Gill, S. R., Pop, M., DeBoy, R. T., Eckburg, P. B., Turnbaugh, P. J., Samuel, B. S., Gordon, J. I., Relman, D. A., Fraser-Liggett, C. M. and Nelson, K. E. (2006). Metagenomic analysis of the human distal gut microbiome. Science. 312:1355–1359.
   PubMed Web of Science ®Google Scholar
• Giongo, A., Gano, K. A., Crabb, D. B., Mukherjee, N., Novelo, L. L., Casella, G., Drew, J. C., Ilonen, J., Knip, M., Hyoty, H., Veijola, R., Simell, T., Simell, O., Neu, J., Wasserfall, C. H., Schatz, D., Atkinson, M. A. and Triplett, E. W. (2011). Toward defining the autoimmune microbiome for type 1 diabetes. The ISME J. 5:82–91.
   PubMed Web of Science ®Google Scholar
• Gravitz, L. (2012). Microbiome: The critters within. Nature. 485:12–13.
   Google Scholar
• Greany, K., Bonorden, M., Hamilton-Reeves, J., Mcmullen, M. and Wangen, K. (2008). Probiotic capsules do not lower plasma lipids in young women and men. Eur. J. Clin. Nutr. 62:232–237.
   PubMed Web of Science ®Google Scholar
• Guha, M. and Mackman, N. (2001). LPS induction of gene expression in human monocytes. Cell. Signal. 13:85–94.
   PubMed Web of Science ®Google Scholar
• Hamden, K., Carreau, S., Boujbiha, M. A., Lajmi, S., Aloulou, D., Kchaou, D. and Elfeki, A. (2008). Hyperglycaemia, stress oxidant, liver dysfunction and histological changes in diabetic male rat pancreas and liver: Protective effect of 17β-estradiol. Steroids. 73:495–501.
   PubMed Web of Science ®Google Scholar
• Harisa, G. I., Taha, E. I., Khalil, A. F. and M.M., S. (2009). Oral administration of lactobacillus acidophilus restores nitric oxide level in diabetic rats. Aust. J. Basic Appl. Sci. 3:2963–2969.
   Google Scholar
• Hayes, M., Stanton, C., Fitzgerald, G. F. and Ross, R. P. (2007). Putting microbes to work: Dairy fermentation, cell factories and bioactive peptides. Part II: Bioactive peptide functions. Biotechnol. J. 2:435–449.
   PubMedGoogle Scholar
• Hempel, S., Newberry, S., Ruelaz, A., Wang, Z., Miles, J. N., Suttorp, M. J., Johnsen, B., Shanman, R., Slusser, W., Fu, N., Smith, A., Roth, B., Polak, J., Motala, A., Perry, T. and Shekelle, P. G. (2011). Safety of probiotics used to reduce risk and prevent or treat disease. Evidence Rep./Technol. Assess. 1–645.
   Google Scholar
• Honda, K., Moto, M., Uchida, N., He, F. and Hashizume, N. (2012). Anti-diabetic effects of lactic acid bacteria in normal and type 2 diabetic mice. J. Clin. Biochem. Nutr. 51:96–101.
   PubMed Web of Science ®Google Scholar
• Hooper, L. V., Midtvedt, T. and Gordon, J. I. (2002). How host-microbial interactions shape the nutrient environment of the mammalian intestine. Ann. Rev. Nutr. 22:283–307.
   PubMed Web of Science ®Google Scholar
• Hotamisligil, G. S. (2006). Inflammation and metabolic disorders. Nature. 444:860–867.
   PubMed Web of Science ®Google Scholar
• Hsieh, F.-C., Lee, C.-L., Chai, C.-Y., Chen, W.-T., Lu, Y.-C. and Wu, C.-S. (2013). Oral administration of Lactobacillus reuteri GMNL-263 improves insulin resistance and ameliorates hepatic steatosis in high fructose-fed rats. Nutr. Metab. 10:35.
   Google Scholar
• Huff, B. A. (2004). Caveat emptor. “Probiotics” might not be what they seem. Canadian Family Physician. 50:583–587.
   PubMed Web of Science ®Google Scholar
• Ishibashi, Yaeshima and Hayasawa (1997). Bifidobacteria: Their significance in human intestinal health. Mal. J. Nutr. 3:149–159.
   Google Scholar
• Ivey, K. L., Hodgson, J. M., Kerr, D. A., Lewis, J. R., Thompson, P. L. and Prince, R. L. (2014). The effects of probiotic bacteria on glycaemic control in overweight men and women: A randomised controlled trial. Eur. J. Clin. Nutr.
   PubMedGoogle Scholar
• Jacobsen, C. N., Rosenfeldt Nielsen, V., Hayford, A. E., Møller, P. L., Michaelsen, K. F., Pærregaard, A., Sandström, B., Tvede, M. and Jakobsen, M. (1999). Screening of probiotic activities of forty-seven strains of lactobacillus spp. by In vitro techniques and evaluation of the colonization ability of five selected strains in humans. Appl. Environ. Microbiol. 65:4949–4956.
   PubMed Web of Science ®Google Scholar
• Kailasapathy, K. and Chin, J. (2000). Survival and therapeutic potential of probiotic organisms with reference to Lactobacillus acidophilus and Bifidobacterium spp. Immunol. Cell Biol. 78:80–88.
   PubMed Web of Science ®Google Scholar
• Kang, J.-H., Yun, S.-I., Park, M.-H., Park, J.-H., Jeong, S.-Y. and Park, H.-O. (2013). Anti-obesity effect of Lactobacillus gasseri BNR17 in high-sucrose diet-induced obese mice. PLoS ONE. 8:e54617.
   PubMed Web of Science ®Google Scholar
• Kankaanpää, P., Sütas, Y., Salminen, S. and Isolauri, E. (2003). Homogenates derived from probiotic bacteria provide down-regulatory signals for peripheral blood mononuclear cells. Food Chem. 83:269–277.
   Web of Science ®Google Scholar
• Karlsson, F. H., Tremaroli, V., Nookaew, I., Bergstrom, G., Behre, C. J., Fagerberg, B., Nielsen, J. and Backhed, F. (2013). Gut metagenome in European women with normal, impaired and diabetic glucose control. Nature. 498:99–103.
   PubMed Web of Science ®Google Scholar
• Kiely, A., Robinson, A., McClenaghan, N. H., Flatt, P. R. and Newsholme, P. (2009). Toll-like receptor agonist induced changes in clonal rat BRIN-BD11 β-cell insulin secretion and signal transduction. J. Endocrinol. 202:365–373.
   PubMed Web of Science ®Google Scholar
• Kim, S.-W., Park, K.-Y., Kim, B., Kim, E. and Hyun, C.-K. (2013). Lactobacillus rhamnosus GG improves insulin sensitivity and reduces adiposity in high-fat diet-fed mice through enhancement of adiponectin production. Biochem. Biophys. Res. Commun. 431:258–263.
   PubMed Web of Science ®Google Scholar
• Kolb, H. and Mandrup-Poulsen, T. (2005). An immune origin of type 2 diabetes? Diab. Tologia. 48:1038–1050.
   PubMed Web of Science ®Google Scholar
• Kullisaar, T., Songisepp, E., Mikelsaar, M., Zilmer, K., Vihalemm, T. and Zilmer, M. (2003). Antioxidative probiotic fermented goats' milk decreases oxidative stress-mediated atherogenicity in human subjects. Brit. J. Nutr. 90:449–456.
   PubMed Web of Science ®Google Scholar
• Kunz, A. N., Noel, J. M. and Fairchok, M. P. (2004). Two cases of Lactobacillus bacteremia during probiotic treatment of short gut syndrome. J. Ped. Gastroenterol. Nutr. 38:457–458.
   PubMed Web of Science ®Google Scholar
• Larsen, N., Vogensen, F. K., van den Berg, F. W. J., Nielsen, D. S., Andreasen, A. S., Pedersen, B. K., Al-Soud, W. A., Sørensen, S. J., Hansen, L. H. and Jakobsen, M. (2010). Gut microbiota in human adults with Type 2 diabetes differs from non-diabetic adults. PLoS ONE. 5:9085.
   PubMed Web of Science ®Google Scholar
• Leuschnera, R. G. K., Robinson, T. P., Hugasa, M., Cocconcellic, P. S., Richard-Forget, F., Kleine, G., Licht, T R., Nguyen-Thea, C., Queroll, A., Richardsoni, M., Suarez, J. E., Tranen, U., Vlakl, J. M. and von Wright, A. (2010). Qualified presumption of safety (QPS): a generic risk assessment approach for biological agents notified to the European Food Safety Authority (EFSA). Trends in Food Science & Technology. 21:425–435.
   Google Scholar
• Lin, C.-H., Lin, C.-C., Shibu, M. A., Liu, C.-S., Kuo, C.-H., Tsai, F.-J., Tsai, C.-H., Hsieh, C.-H., Chen, Y.-H. and Huang, C.-Y. (2014). Oral Lactobacillus reuteri GMN-32 treatment reduces blood glucose concentrations and promotes cardiac function in rats with streptozotocin-induced diabetes mellitus. Brit. J. Nutr. 111:598–605.
   PubMed Web of Science ®Google Scholar
• Lin, M.-Y. and Chang, F.-J. (2000). Antioxidative effect of intestinal bacteria bifidobacterium longum ATCC 15708 and Lactobacillus acidophilus ATCC 4356. Digest. Dis. Sci. 45:1617–1622.
   PubMed Web of Science ®Google Scholar
• Lindsay, K. L., Kennelly, M., Culliton, M., Smith, T., Maguire, O. C., Shanahan, F., Brennan, L. and McAuliffe, F. M. (2014). Probiotics in obese pregnancy do not reduce maternal fasting glucose: A double-blind, placebo-controlled, randomized trial. Am. J. Clin. Nutr. 99(6):1432–1439.
   Google Scholar
• Louis, P. and Flint, H. J. (2009). Diversity, metabolism and microbial ecology of butyrate-producing bacteria from the human large intestine. FEMS Microbiol. Lett. 294:1–8.
   PubMed Web of Science ®Google Scholar
• Louis, P., Scott, K. P., Duncan, S. H. and Flint, H. J. (2007). Understanding the effects of diet on bacterial metabolism in the large intestine. J. Appl. Microbiol. 102:1197–1208.
   PubMed Web of Science ®Google Scholar
• Luoto, R., Laitinen, K., Nermes, M. and Isolauri, E. (2010). Impact of maternal probiotic-supplemented dietary counselling on pregnancy outcome and prenatal and postnatal growth: a double-blind, placebo-controlled study. Brit. J. Nutr. 103:1792–1799.
   PubMed Web of Science ®Google Scholar
• Lyssenko, V., Jonsson, A., Almgren, P., Pulizzi, N., Isomaa, B., Tuomi, T., Berglund, G., Altshuler, D., Nilsson, P. and Groop, L. (2008). Clinical risk factors, DNA variants, and the development of type 2 diabetes. New Engl. J. Med. 359:2220–2232.
   PubMed Web of Science ®Google Scholar
• Magrone, T. and Jirillo, E. (2013). The interaction between gut microbiota and age-related changes in immune function and inflammation. Immun. Ageing. 10:31.
   PubMed Web of Science ®Google Scholar
• Maritim, A. C., Sanders, R. A. and Watkins, J. B. (2003). Diabetes, oxidative stress, and antioxidants: A review. J. Biochem. Mol. Toxicol. 17:24–38.
   PubMed Web of Science ®Google Scholar
• Maslowski, K. M., Vieira, A. T., Ng, A., Kranich, J., Sierro, F., Yu, D., Schilter, H. C., Rolph, M. S., Mackay, F., Artis, D., Xavier, R. J., Teixeira, M. M. and Mackay, C. R. (2009). Regulation of inflammatory responses by gut microbiota and chemoattractant receptor GPR43. Nature. 461:1282–1286.
   PubMed Web of Science ®Google Scholar
• Matsuzaki, T., Yamazaki, R., Hashimoto, S. and Yokokura, T. (1997). Antidiabetic effects of an oral administration of lactobacillus casei in a non-insulin-dependent diabetes mellitus (NIDDM) model using KK-Ay mice. Endocr. J. 44:357–365.
   PubMed Web of Science ®Google Scholar
• Mazloom, Z., Yousefinejad, A. and Dabbaghmanesh, M. H. (2013). Effect of probiotics on lipid profile, glycemic control, insulin action, oxidative stress, and inflammatory markers in patients with type 2 diabetes: A clinical trial. Iran. J. Med. Sci. 38:38–43.
   PubMedGoogle Scholar
• De Groote, M. A., Frank, D. N., Dowell, E., Glode, M. P. and Pace, N. R. (2005). Lactobacillus rhamnosus Gg bacteremia associated with probiotic use in a child with short gut syndrome. Ped. Infect. Dis. J. 24:278–280.
   PubMed Web of Science ®Google Scholar
• Mattarelli, P., Brandi, G., Modesto, M. and Biavati, B. (2002). Discrepancy between declared and recovered bifidobacteria in a human probiotic. Ann. Microbiol. 52:283–286.
   Google Scholar
• Moroti, C., Magri, L., De Rensis, C., Costa, M. and Sivieri, K. (2010). Effect of the consumption of a symbiotic shake on the intestinal microflora of erdely people. Int. J. Probiotics Prebiotics. 2:1–10.
   Google Scholar
• Moroti, C., Souza Magri, L., de Rezende Costa, M., Cavallini, D. and Sivieri, K. (2012). Effect of the consumption of a new symbiotic shake on glycemia and cholesterol levels in elderly people with type 2 diabetes mellitus. Lipids Health Dis. 11:29.
   PubMed Web of Science ®Google Scholar
• Muro Urista, C., Álvarez Fernández, R., Riera Rodriguez, F., Arana Cuenca, A. and Téllez Jurado, A. (2011). Review: Production and functionality of active peptides from milk. Food Sci. Technol. Int. 17:293–317.
   PubMed Web of Science ®Google Scholar
• Musso, G., Gambino, R. and Cassader, M. (2011). Interactions between gut microbiota and host metabolism predisposing to obesity and diabetes. Ann. Rev. Med. 62:361–380.
   PubMed Web of Science ®Google Scholar
• Naruszewicz, M., Johansson, M.-L., Zapolska-Downar, D. and Bukowska, H. (2002). Effect of Lactobacillus plantarum 299v on cardiovascular disease risk factors in smokers. Am. J. Clin. Nutr. 76:1249–1255.
   PubMed Web of Science ®Google Scholar
• Neish, A. S. (2009). Microbes in Gastrointestinal Health and Disease. Gastroenterology. 136:65–80.
   PubMed Web of Science ®Google Scholar
• Nguyen, A. T., Mandard, S., Dray, C., Deckert, V., Valet, P., Besnard, P., Drucker, D. J., Lagrost, L. and Grober, J. (2014). Lipopolysaccharides-mediated increase in glucose-stimulated insulin secretion: Involvement of the GLP-1 pathway. Diabetes. 63:471–482.
   PubMed Web of Science ®Google Scholar
• Noble, D., Mathur, R., Dent, T., Meads, C. and Greenhalgh, T. (2011). Risk models and scores for type 2 diabetes: Systematic review. BMJ. 343.
   Web of Science ®Google Scholar
• O'Hara, A. M. and Shanahan, F. (2006). The gut flora as a forgotten organ. EMBO Rep. 7:688–693.
   PubMed Web of Science ®Google Scholar
• Paineau, D., Carcano, D., Leyer, G., Darquy, S., Alyanakian, M.-A., Simoneau, G., Bergmann, J.-F., Brassart, D., Bornet, F. and Ouwehand, A. C. (2008). Effects of seven potential probiotic strains on specific immune responses in healthy adults: A double-blind, randomized, controlled trial. FEMS Immunol. Med. Microbiol. 53:107–113.
   PubMed Web of Science ®Google Scholar
• Panwar, H., Rashmi, H. M., Batish, V. K. and Grover, S. (2013). Probiotics as potential biotherapeutics in the management of type 2 diabetes – prospects and perspectives. Diabetes/Metab. Res. Rev. 29:103–112.
   PubMed Web of Science ®Google Scholar
• Petruzzelli, M. and Moschetta, A. (2010). Intestinal ecology in the metabolic syndrome. Cell Metab. 11:345–346.
   PubMed Web of Science ®Google Scholar
• Pickup, J. C., Chusney, G. D., Thomas, S. M. and Burt, D. (2000). Plasma interleukin-6, tumour necrosis factor α and blood cytokine production in type 2 diabetes. Life Sci. 67:291–300.
   PubMed Web of Science ®Google Scholar
• Qin, J., Li, Y., Cai, Z., Li, S., Zhu, J., Zhang, F., Liang, S., Zhang, W., Guan, Y., Shen, D., Peng, Y., Zhang, D., Jie, Z., Wu, W., Qin, Y., Xue, W., Li, J., Han, L., Lu, D., Wu, P., Dai, Y., Sun, X., Li, Z., Tang, A., Zhong, S., Li, X., Chen, W., Xu, R., Wang, M., Feng, Q., Gong, M., Yu, J., Zhang, Y., Zhang, M., Hansen, T., Sanchez, G., Raes, J., Falony, G., Okuda, S., Almeida, M., LeChatelier, E., Renault, P., Pons, N., Batto, J. M., Zhang, Z., Chen, H., Yang, R., Zheng, W., Yang, H., Wang, J., Ehrlich, S. D., Nielsen, R., Pedersen, O. and Kristiansen, K. (2012). A metagenome-wide association study of gut microbiota in type 2 diabetes. Nature. 490:55–60.
   PubMed Web of Science ®Google Scholar
• Rains, J. L. and Jain, S. K. (2011). Oxidative stress, insulin signaling, and diabetes. Free Radical Biol. Med. 50:567–575.
   PubMed Web of Science ®Google Scholar
• Ritchie, M. L. and Romanuk, T. N. (2012). A meta-analysis of probiotic efficacy for gastrointestinal diseases. PLoS ONE. 7:e34938.
   PubMed Web of Science ®Google Scholar
• Roselino, M., Pauly-Silveira, N., Cavallini, D., Celiberto, L., Pinto, R., Vendramini, R. and Rossi, E. (2012). A potential synbiotic product improves the lipid profile of diabetic rats. Lipids Health Dis. 11:114.
   PubMed Web of Science ®Google Scholar
• Sabeena Farvin, K. H., Baron, C. P., Nielsen, N. S., Otte, J. and Jacobsen, C. (2010). Antioxidant activity of yoghurt peptides: Part 2 – Characterisation of peptide fractions. Food Chem. 123:1090–1097.
   Web of Science ®Google Scholar
• Sanders, M. E., Akkermans, L. M. A., Haller, D., Hammerman, C., Heimbach, J. T., Hörmannsperger, G. and Huys, G. (2010). Safety assessment of probiotics for human use. Gut. Microbes. 1:164–185.
   PubMed Web of Science ®Google Scholar
• Santos, M. S., Meydani, S. N., Leka, L., Wu, D., Fotouhi, N., Meydani, M., Hennekens, C. H. and Gaziano, J. M. (1996). Natural killer cell activity in elderly men is enhanced by beta-carotene supplementation. The Am. J. Clin. Nutr. 64:772–777.
   PubMed Web of Science ®Google Scholar
• Sato, J., Kanazawa, A., Ikeda, F., Yoshihara, T., Goto, H., Abe, H., Komiya, K., Kawaguchi, M., Shimizu, T., Ogihara, T., Tamura, Y., Sakurai, Y., Yamamoto, R., Mita, T., Fujitani, Y., Fukuda, H., Nomoto, K., Takahashi, T., Asahara, T., Hirose, T., Nagata, S., Yamashiro, Y. and Watada, H. (2014). Gut dysbiosis and detection of “Live Gut Bacteria” in blood of Japanese patients with type 2 diabetes. Diabetes Care. 37(8):2343–2350.
   Google Scholar
• Scheffel, R. S., Bortolanza, D., Weber, C. S., Costa, L. A. d., Canani, L. H., Santos, K. G. d., Crispim, D., Roisenberg, I., Lisbôa, H. R. K., Tres, G. S., Tschiedel, B. and Gross, J. L. (2004). Prevalência de complicações micro e macrovasculares e de seus fatores de risco em pacientes com diabetes melito do tipo 2 em atendimento ambulatorial. Revista da Associação Médica Brasileira. 50:263–267.
   PubMedGoogle Scholar
• Schiffrin, E. J., Morley, J. E., Donnet-Hughes, A. and Guigoz, Y. (2010). The inflammatory status of the elderly: The intestinal contribution. Mutat. Res./Fund. Mol. Mech. Mut. 690:50–56.
   PubMed Web of Science ®Google Scholar
• Schrezenmeir, J. and de Vrese, M. (2001). Probiotics, prebiotics, and synbiotics—approaching a definition. Am. J. Clin. Nutr. 73:361s-364s.
   PubMed Web of Science ®Google Scholar
• Scully, T. (2012). Diabetes in numbers. Nature. 485:2–3.
   PubMedGoogle Scholar
• Songisepp, E., Kals, J., Kullisaar, T., Mandar, R., Hutt, P., Zilmer, M. and Mikelsaar, M. (2005). Evaluation of the functional efficacy of an antioxidative probiotic in healthy volunteers. Nutr. J. 4:22.
   PubMed Web of Science ®Google Scholar
• Spranger, J., Kroke, A., Möhlig, M., Hoffmann, K., Bergmann, M. M., Ristow, M., Boeing, H. and Pfeiffer, A. F. H. (2003). Inflammatory cytokines and the risk to Develop type 2 diabetes: Results of the prospective population-based European prospective investigation into Cancer and Nutrition (EPIC)-Potsdam Study. Diabetes. 52:812–817.
   PubMed Web of Science ®Google Scholar
• Stephens, J. W., Khanolkar, M. P. and Bain, S. C. (2009). The biological relevance and measurement of plasma markers of oxidative stress in diabetes and cardiovascular disease. Atherosclerosis. 202:321–329.
   PubMed Web of Science ®Google Scholar
• Stratton, I. M., Adler, A. I., Neil, H. A. W., Matthews, D. R., Manley, S. E., Cull, C. A., Hadden, D., Turner, R. C. and Holman, R. R. (2000). Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study. BMJ. 321:405–412.
   PubMed Web of Science ®Google Scholar
• Tabuchi, M., Ozaki, M., Tamura, A., Yamada, N., Ishida, T., Hosoda, M. and Hosono, A. (2003). Antidiabetic effect of lactobacillus GG in streptozotocin-induced diabetic rats. Biosci. Biotechnol. Biochem. 67:1421–1424.
   PubMed Web of Science ®Google Scholar
• Takeda, K. and Okumura, K. (2007). Effects of a fermented milk drink containing lactobacillus casei strain shirota on the human NK-cell activity. J. Nutr. 137:791S–793S.
   PubMed Web of Science ®Google Scholar
• Tolhurst, G., Heffron, H., Lam, Y. S., Parker, H. E., Habib, A. M., Diakogiannaki, E., Cameron, J., Grosse, J., Reimann, F. and Gribble, F. M. (2012). Short-chain fatty acids stimulate glucagon-like peptide-1 secretion via the G-Protein–coupled receptor FFAR2. Diabetes. 61:364–371.
   PubMed Web of Science ®Google Scholar
• Tsukumo, D. M. L., Carvalho-Filho, M. A., Carvalheira, J. B. C., Prada, P. O., Hirabara, S. M., Schenka, A. A., Araújo, E. P., Vassallo, J., Curi, R., Velloso, L. A. and Saad, M. J. A. (2007). Loss-of-function mutation in toll-like receptor 4 prevents diet-induced obesity and insulin resistance. Diabetes. 56:1986–1998.
   PubMed Web of Science ®Google Scholar
• Turnbaugh, P. J., Hamady, M., Yatsunenko, T., Cantarel, B. L., Duncan, A., Ley, R. E., Sogin, M. L., Jones, W. J., Roe, B. A., Affourtit, J. P., Egholm, M., Henrissat, B., Heath, A. C., Knight, R. and Gordon, J. I. (2009). A core gut microbiome in obese and lean twins. Nature. 457:480–484.
   PubMed Web of Science ®Google Scholar
• Uskova, M. A. and Kravchenko, L. V. (2009). Antioxidant properties of lactic acid bacteria–probiotic and yogurt strains. Vopr. Pitan. 78:18–23.
   PubMedGoogle Scholar
• Vijay-Kumar, M., Aitken, J. D., Carvalho, F. A., Cullender, T. C., Mwangi, S., Srinivasan, S., Sitaraman, S. V., Knight, R., Ley, R. E. and Gewirtz, A. T. (2010). Metabolic syndrome and altered gut microbiota in mice lacking Toll-like receptor 5. Science. 328.
   PubMed Web of Science ®Google Scholar
• Vrieze, A., Van Nood, E., Holleman, F., Salojärvi, J., Kootte, R. S., Bartelsman, J. F. W. M., Dallinga–Thie, G. M., Ackermans, M. T., Serlie, M. J., Oozeer, R., Derrien, M., Druesne, A., Van Hylckama Vlieg, J. E. T., Bloks, V. W., Groen, A. K., Heilig, H. G. H. J., Zoetendal, E. G., Stroes, E. S., de Vos, W. M., Hoekstra, J. B. L. and Nieuwdorp, M. (2012). Transfer of intestinal microbiota from lean donors increases insulin sensitivity in individuals with metabolic syndrome. Gastroenterology. 143:913–916.e917.
   PubMed Web of Science ®Google Scholar
• Walker, A. W., Duncan, S. H., McWilliam Leitch, E. C., Child, M. W. and Flint, H. J. (2005). pH and peptide Supply can radically alter bacterial populations and short-chain fatty acid ratios within microbial Communities from the human colon. Appl. Environ. Microbiol. 71:3692–3700.
   PubMed Web of Science ®Google Scholar
• Wallace, T. C. and MacKay, D. (2011). The safety of probiotics: Considerations following the 2011 U.S. agency for health research and quality report. J. Nutr. 141:1923–1924.
   PubMed Web of Science ®Google Scholar
• Wannaprasat, W., Koowatananukul, C., Ekkapobyotin, C. and Chuanchuen, R. (2009). Quality analysis of commercial probiotic products for food animals. Southeast Asian Journal of Tropical Medicine and Public Health, 40:1103–1112.
   PubMed Web of Science ®Google Scholar
• Wang, X., Bao, W., Liu, J., OuYang, Y.-Y., Wang, D., Rong, S., Xiao, X., Shan, Z.-L., Zhang, Y., Yao, P. and Liu, L.-G. (2013). Inflammatory markers and risk of type 2 diabetes: A systematic review and meta-analysis. Diabetes Care. 36:166–175.
   PubMed Web of Science ®Google Scholar
• Whelan, K. and Myers, C. E. (2010). Safety of probiotics in patients receiving nutritional support: A systematic review of case reports, randomized controlled trials, and nonrandomized trials. Am. J. Clin. Nutr. 91:687–703.
   PubMed Web of Science ®Google Scholar
• Williams, N. T. (2010). Probiotics. Am. J. Health-Syst. Pharm. 67:449–458.
   PubMed Web of Science ®Google Scholar
• World Health Organization (2012). World Diabetes Day 2012, World Health Organization.
   Google Scholar
• Wu, X., Ma, C., Han, L., Nawaz, M., Gao, F., Zhang, X., Yu, P., Zhao, C. a., Li, L., Zhou, A., Wang, J., Moore, J., Cherie Millar, B. and Xu, J. (2010). Molecular characterisation of the faecal microbiota in patients with type II diabetes. Curr. Microbiol. 61:69–78.
   PubMed Web of Science ®Google Scholar
• Yadav, H., Jain, S. and Sinha, P. (2007). Antidiabetic effect of probiotic dahi containing lactobacillus acidophilus and lactobacillus casei in high fructose fed rats. Nutr. 23:62–68.
   PubMed Web of Science ®Google Scholar
• Yadav, H., Jain, S. and Sinha, P. R. (2008). Oral administration of dahi containing probiotic Lactobacillus acidophilus and Lactobacillus casei delayed the progression of streptozotocin-induced diabetes in rats. J. Dairy Res. 75:189–195.
   PubMed Web of Science ®Google Scholar
• Yadav, H., Lee, J.-H., Lloyd, J., Walter, P. and Rane, S. G. (2013). Beneficial metabolic effects of a probiotic via butyrate induced GLP-1 secretion. J. Biol. Chem.
   Web of Science ®Google Scholar
• Yun, S., Park, H. and Kang, J. (2009). Effect of lactobacillus gasseri BNR17 on blood glucose levels and body weight in a mouse model of type 2 diabetes. J. Appl. Microbiol. 107:1681–1686.
   PubMed Web of Science ®Google Scholar
• Zein, E. F., Karaa, S., Chemaly, A., Saidi, I., Daou-Chahine, W. and Rohban, R. (2008). Lactobacillus rhamnosus septicemia in a diabetic patient associated with probiotic use: A case report. Ann. Biol. Clin. 66:195–198.
   PubMedGoogle Scholar